Roche, Regeneron join forces on COVID-19 antibody
Despite hundreds of potential therapies for COVID-19 looking to make their case, very few have crossed the finish line. One promising candidate, Regeneron's two-antibody cocktail, has earned early plaudits—and now a pharma giant is jumping aboard to boost manufacturing in a big way.
Regeneron will team up with Swiss drugmaker Roche to more than triple production of the New York biotech's COVID-19 antibody therapy, REGN-COV2, for a planned global rollout, the partners said Wednesday.
Under a seven-year licensing deal, Regeneron and Roche will each reserve manufacturing capacity for the therapy in preparation for future regulatory approvals, with Regeneron handling the U.S. rollout and Roche taking on distribution elsewhere.
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$1.8E+2/UNIT FOB
2026-09-02
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
UK AGC Plans to Close PFAS Plant as Pressure on Europe’s Fluorochemicals Sector Intensifies
-
Sinopec Completes CNAF Restructuring, Integrating the Entire Aviation Fuel Chain
-
China Eases July Fuel Export Curbs as Zhejiang Petrochemical Resumes Shipments
-
China’s Polyolefin Exports Keep Surging, Reversing the Global Plastics Trade Map
-
Sanofi’s $2.2 Billion Dynavax Acquisition: Why Big Pharma Is Rebuilding the Global Vaccine Order
-
Typhoon Bavi Hits Zhejiang and Fujian, Putting Two Major Petrochemical Hubs at Logistics Risk
-
Nippon Paint Offers $8.55 Billion for AkzoNobel’s Decorative Paints Business
-
AstraZeneca’s Wainua Fails Phase III Heart Trial, Wiping Out About $27 Billion in Market Value
-
IFF to Establish Scent Creative Center in Mumbai
-
Wanhua Chemical's Hungarian 650,000-ton MDI/TDI Plant to Shut Down for 35-Day Maintenance
Recommend Reading
-
![From Desert Sands to Dining Tables: Arab Food & Beverage Sector Emerges as Investment Powerhouse]()
From Desert Sands to Dining Tables: Arab Food & Beverage Sector Emerges as Investment Powerhouse
-
![The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution]()
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
![Korea’s Petrochemical Pivot: Industry Embraces Historic Restructuring to Slash Overcapacity]()
Korea’s Petrochemical Pivot: Industry Embraces Historic Restructuring to Slash Overcapacity
-
![Beiersdorf Launches Eucerin Skincare Brand in Japan]()
Beiersdorf Launches Eucerin Skincare Brand in Japan
-
![Haldia Petrochemicals Pipeline Fire in India Adds Uncertainty to Asia's Naphtha Market]()
Haldia Petrochemicals Pipeline Fire in India Adds Uncertainty to Asia's Naphtha Market
-
![This Week's Activated Carbon Prices Remain Stable (5.18-5.22) in China]()
This Week's Activated Carbon Prices Remain Stable (5.18-5.22) in China
-
![2025 Cyclohexanone Market Review and 2026 Outlook in China]()
2025 Cyclohexanone Market Review and 2026 Outlook in China
-
![In recent ten days, the phosphate market price in China has shown a strong increase]()
In recent ten days, the phosphate market price in China has shown a strong increase
-
![Supply-demand contradiction difficult to alleviate, polyethylene remains weak]()
Supply-demand contradiction difficult to alleviate, polyethylene remains weak
-
![This Week Aniline Market Weakens in China (5.18-5.22)]()
This Week Aniline Market Weakens in China (5.18-5.22)
